M. Downing

419 total citations
20 papers, 293 citations indexed

About

M. Downing is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Downing has authored 20 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Biochemistry, 11 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Downing's work include Metabolism and Genetic Disorders (17 papers), Biochemical and Molecular Research (5 papers) and Mitochondrial Function and Pathology (4 papers). M. Downing is often cited by papers focused on Metabolism and Genetic Disorders (17 papers), Biochemical and Molecular Research (5 papers) and Mitochondrial Function and Pathology (4 papers). M. Downing collaborates with scholars based in United Kingdom, United States and Denmark. M. Downing's co-authors include N. J. Manning, S. E. Olpin, R. J. Pollitt, James R. Bonham, Mark Sharrard, Wendy Cammer, M S Tanner, Jeffrey C. Allen, Brage Storstein Andresen and Morteza Pourfarzam and has published in prestigious journals such as Clinical Chemistry, Journal of Histochemistry & Cytochemistry and Journal of Inherited Metabolic Disease.

In The Last Decade

M. Downing

19 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Downing United Kingdom 11 203 190 62 55 29 20 293
J. B. de Klerk Netherlands 5 208 1.0× 213 1.1× 40 0.6× 66 1.2× 11 0.4× 5 303
Ljerka Cvitanović-Šojat Croatia 8 273 1.3× 229 1.2× 93 1.5× 60 1.1× 8 0.3× 16 377
Adrya Stembridge United States 5 287 1.4× 155 0.8× 44 0.7× 110 2.0× 18 0.6× 8 323
Paul B. Wieser United States 8 106 0.5× 127 0.7× 28 0.5× 123 2.2× 37 1.3× 13 335
M. Ciman Italy 11 317 1.6× 238 1.3× 42 0.7× 161 2.9× 48 1.7× 17 446
G. N. Thompson Singapore 11 210 1.0× 109 0.6× 29 0.5× 200 3.6× 46 1.6× 12 410
Lisa Sniderman King United States 7 191 0.9× 90 0.5× 75 1.2× 75 1.4× 23 0.8× 12 263
Mojca Žerjav Tanšek Slovenia 11 216 1.1× 209 1.1× 77 1.2× 177 3.2× 64 2.2× 45 579
Mary J. Schmidt United States 7 212 1.0× 160 0.8× 27 0.4× 82 1.5× 14 0.5× 9 349
Cristiane Cecatto Brazil 13 215 1.1× 248 1.3× 14 0.2× 41 0.7× 13 0.4× 27 340

Countries citing papers authored by M. Downing

Since Specialization
Citations

This map shows the geographic impact of M. Downing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Downing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Downing more than expected).

Fields of papers citing papers by M. Downing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Downing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Downing. The network helps show where M. Downing may publish in the future.

Co-authorship network of co-authors of M. Downing

This figure shows the co-authorship network connecting the top 25 collaborators of M. Downing. A scholar is included among the top collaborators of M. Downing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Downing. M. Downing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Besley, G. T. N., Neil Dalton, M. Downing, et al.. (2010). Relationship of Octanoylcarnitine Concentrations to Age at Sampling in Unaffected Newborns Screened for Medium-Chain Acyl-CoA Dehydrogenase Deficiency. Clinical Chemistry. 56(6). 1015–1021. 9 indexed citations
2.
Garbade, Sven F., Claus‐Dieter Langhans, Georg F. Hoffmann, et al.. (2008). Qualitative urinary organic acid analysis: Methodological approaches and performance. Journal of Inherited Metabolic Disease. 31(6). 690–696. 13 indexed citations
3.
Khalid, Mona Aeysha, Mario Cortina‐Borja, Brage Storstein Andresen, et al.. (2008). Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants. Journal of Medical Screening. 15(3). 112–117. 15 indexed citations
4.
Pourfarzam, Morteza, et al.. (2006). Consensus case definitions for MCADD among infants with presumptive positive newborn screening results. Journal of Inherited Metabolic Disease. 1 indexed citations
5.
6.
Downing, M., et al.. (2005). Newborn Screening for Medium Chain Acyl CoA Dehydrogenase Deficiency: acylcarnitine C8/C10 ratio at day 6 differentiates affected cases from carriers. UCL Discovery (University College London). 2 indexed citations
7.
Olpin, S. E., Brage Storstein Andresen, Claus Bischoff, et al.. (2004). Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. Journal of Inherited Metabolic Disease. 28(4). 533–544. 54 indexed citations
8.
Olpin, S. E., Jason D. Allen, James R. Bonham, et al.. (2001). Features of carnitine palmitoyltransferase type I deficiency. Journal of Inherited Metabolic Disease. 24(1). 35–42. 32 indexed citations
9.
Manning, N. J., S. E. Olpin, R. J. Pollitt, et al.. (2000). Fumarate hydratase deficiency: increased fumaric acid in amniotic fluid of two affected pregnancies. Journal of Inherited Metabolic Disease. 23(7). 757–759. 6 indexed citations
10.
Downing, M., Jeffrey C. Allen, James R. Bonham, et al.. (1999). Problems in the detection of fatty acid oxidation defects: Experience of a quality assurance programme for qualitative urinary organic acid analysis. Journal of Inherited Metabolic Disease. 22(3). 289–292. 7 indexed citations
11.
Bonham, James R., Philip A. I. Guthrie, M. Downing, et al.. (1999). The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. Journal of Inherited Metabolic Disease. 22(2). 174–184. 26 indexed citations
12.
Manning, N. J., James R. Bonham, M. Downing, et al.. (1999). Normal acylcarnitines in maternal urine during a pregnancy affected by glutaric aciduria type II. Journal of Inherited Metabolic Disease. 22(1). 88–89. 7 indexed citations
13.
Olpin, S. E., James R. Bonham, M. Downing, et al.. (1997). Carnitine‐acylcarnitine translocase deficiency ‐ a mild phenotype. Journal of Inherited Metabolic Disease. 20(5). 714–715. 29 indexed citations
14.
Bonham, James R., M. Downing, R. J. Pollitt, et al.. (1994). Quality Assessment of Urinary Organic Acid Analysis. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 31(2). 129–133. 22 indexed citations
15.
Downing, M.. (1993). Introduction to cataloging and classification. The Journal of Academic Librarianship. 19(1). 34–34. 2 indexed citations
16.
Downing, M., et al.. (1992). Metabolic deficiencies and SIDS.. PubMed. 45(11 Suppl). 33–8. 14 indexed citations
17.
Cammer, Wendy & M. Downing. (1991). Localization of the multifunctional protein CAD in astrocytes of rodent brain.. Journal of Histochemistry & Cytochemistry. 39(5). 695–700. 16 indexed citations
18.
Cammer, Wendy, et al.. (1991). Immunocytochemical staining of the RLM6 form of cytochrome P-450 in oligodendrocytes and myelin of rat brain.. Journal of Histochemistry & Cytochemistry. 39(8). 1089–1094. 12 indexed citations
19.
Downing, M., Philip G. Rose, Malcolm J. Bennett, N. J. Manning, & R. J. Pollitt. (1989). Generalised Dicarboxylic Aciduria: A Common Finding in Neonates. Journal of Inherited Metabolic Disease. 12(S2). 321–324. 10 indexed citations
20.
Downing, M.. (1985). That All May Read: Library Services for Blind and Physically Handicapped People.. The Library Quarterly. 55(1). 110–111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. B. de Klerk Breakdown of academic impact, for papers by Ljerka Cvitanović-Šojat Breakdown of academic impact, for papers by Adrya Stembridge Breakdown of academic impact, for papers by Paul B. Wieser Breakdown of academic impact, for papers by M. Ciman Breakdown of academic impact, for papers by G. N. Thompson Breakdown of academic impact, for papers by Lisa Sniderman King Breakdown of academic impact, for papers by Mojca Žerjav Tanšek Breakdown of academic impact, for papers by Mary J. Schmidt Breakdown of academic impact, for papers by Cristiane Cecatto
Rankless by CCL
2026